IGEA Pharma (Switzerland) Today

IGPH -  Switzerland Stock  

CHF 0.37  0.02  5.13%

IGEA Pharma is selling for under 0.37 as of the 1st of August 2021; that is -5.13 percent down since the beginning of the trading day. The stock's lowest day price was 0.34. IGEA Pharma has a very high chance of experiencing financial distress in the next few years of operation. It also did not have a very good performance during the last 90 trading days. Equity ratings for IGEA Pharma N are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 3rd of June 2021 and ending today, the 1st of August 2021. Click here to learn more.
 Market Performance
1 of 100
  Odds Of Distress
Over 77
IGEA Pharma N cannot be verified against its exchange. It appears that IGEA Pharma is not available for investing at the moment. Please verify the symbol is currently traded on Switzerland Exchange. If you still believe the symbol you are trying to look up is valid please let us know and we will check it as soon as possible.
Refresh

IGEA Pharma Stock Profile

IGEA Pharma N.V. commercializes health-tech and med-tech products and devices in in the United States. IGEA Pharma N.V. was incorporated in 2015 and is headquartered in Hoofddorp, the Netherlands. IGEA Pharma is traded on Switzerland Exchange in Switzerland. more on IGEA Pharma
IGEA Pharma N has very high historical volatility over the last 90 days
IGEA Pharma N has some characteristics of a very speculative penny stock
IGEA Pharma N has high likelihood to experience some financial distress in the next 2 years
The company reported the revenue of 47.5 K. Net Loss for the year was (1.51 M) with loss before overhead, payroll, taxes, and interest of (271.6 K).
IGEA Pharma N has accumulated about 360 K in cash with (989.7 K) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.01.
Roughly 60.0% of the company shares are held by company insiders
Legal NameIGEA Pharma N
Macroaxis Advice
Unlike general analyst consensus, Macroaxis buy hold or sell recommendation is provided in the context of your current investment horizon and risk tolerance. The advice algorithm takes into account all of IGEA Pharma's available fundamental, technical, and predictive indicators. Your current horizon is 90 days - details
Strong SellOvervalued
IGEA Pharma N (IGPH) is traded on Switzerland Exchange in Switzerland and employs 2 people. The company currently falls under 'Nano-Cap' category with current market capitalization of 9.42 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate IGEA Pharma's market, we take the total number of its shares issued and multiply it by IGEA Pharma's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities. IGEA Pharma N operates under Healthcare sector and is part of Diagnostics & Research industry. The entity has 25.05 M outstanding shares. IGEA Pharma N has accumulated about 360 K in cash with (989.7 K) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.01.
Check IGEA Pharma Probability Of Bankruptcy

IGEA Pharma N Risk Profiles

Investors will always prefer to have the highest possible return on investment while minimizing volatility. IGEA Pharma market risk premium is the additional return an investor will receive from holding IGEA Pharma long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in IGEA Pharma. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although IGEA Pharma's alpha and beta are two of the key measurements used to evaluate IGEA Pharma's performance over the market, the standard measures of volatility play an important role as well.

IGEA Pharma Stock Against Markets

Picking the right benchmark for IGEA Pharma stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in IGEA Pharma stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for IGEA Pharma is critical whether you are bullish or bearish towards IGEA Pharma N at a given time.
IGEA Pharma N cannot be verified against its exchange. It appears that IGEA Pharma is not available for investing at the moment. Please verify the symbol is currently traded on Switzerland Exchange. If you still believe the symbol you are trying to look up is valid please let us know and we will check it as soon as possible.
Refresh

Try Other Stock Suggestions

Be your own money manager

Our tools can tell you how much better you can do entering a position in IGEA Pharma without increasing your portfolio risk or giving up expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate.risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Portfolio Anywhere Now

   

Portfolio Anywhere

Track or share privately all of your investments from the convenience of any device
All  Next Launch Module
Please see Risk vs Return Analysis. Note that the IGEA Pharma N information on this page should be used as a complementary analysis to other IGEA Pharma's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.

Other Tools for IGEA Pharma Stock

When running IGEA Pharma N price analysis, check to measure IGEA Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy IGEA Pharma is operating at the current time. Most of IGEA Pharma's value examination focuses on studying past and present price action to predict the probability of IGEA Pharma's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move IGEA Pharma's price. Additionally, you may evaluate how the addition of IGEA Pharma to your portfolios can decrease your overall portfolio volatility.
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Go
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Go
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Go
Fundamental Analysis
View fundamental data based on most recent published financial statements
Go
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Go
Bond Directory
Find actively traded corporate debentures issued by US companies
Go
Global Correlations
Find global opportunities by holding instruments from different markets
Go
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Go
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Go
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Go
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Go